SMMT

Summit Therapeutics
D

SMMT

17.820
USD
1.64
(10.14%)
مغلق
حجم التداول
86,338
الربح لكل سهم
-0
العائد الربحي
-
P/E
-14
حجم السوق
13,265,966,027
أصول ذات صلة الأخبار المقالات

العنوان: Summit Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate isridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.